SEC Form 4 · accession 0001415889-17-001224
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randal R Betz
Director
Period of report
Jul 14, 2017
Accepted (ET)
Jul 18, 2017 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 14, 2017 | P | 10,989 | $0.91 | A | 152,016 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase WarrantF2 | $1.15 | Jul 14, 2017 | P | 5,495 | A | Jan 14, 2018 | Jan 14, 2023 | Common Stock | 5,495 | 5,495 | D |
Explanation of responses
- F1The shares were purchased as part of a private placement offering for $0.91 per share of common stock.
- F2The warrants were purchased as part of a private placement offering for $0.125 per warrant at an exercise price per share equal to $1.15 per share for a period of five (5) years commencing six (6) months from the date of issuance.